Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 247 (5), 693-7

Evaluation of Traditional and Emerging Cardiovascular Risk Factors in Patients With Non-Arteritic Anterior Ischemic Optic Neuropathy: A Case-Control Study

Affiliations

Evaluation of Traditional and Emerging Cardiovascular Risk Factors in Patients With Non-Arteritic Anterior Ischemic Optic Neuropathy: A Case-Control Study

Barbara Giambene et al. Graefes Arch Clin Exp Ophthalmol.

Abstract

Background: Non-arteritic anterior ischemic optic neuropathy (NAION) is a multifactorial disease that is caused by an infarction of the vessels that supply the optic nerve head. This study aims at evaluating the role of traditional and emerging cardiovascular risk factors on the development of NAION.

Methods: A total of 85 newly diagnosed NAION patients and 107 age- and gender-matched healthy controls were studied. All participants underwent blood testing for homocysteine and lipoprotein(a). Plasma levels of vitamin B6 and B12, and folic acid were also determined. Plasma values of all these parameters were evaluated as continuous variables, by a logarithmic transformation. In addition, traditional cardiovascular risk factors were considered.

Results: With univariate analysis, higher values of homocysteine and Lp(a) (OR 4.24, 95% CI 2.01-8.94, p < 0.0001; OR 1.32, 95% CI 1.04-1.67, p = 0.03, respectively) and lower values of vitamin B6 (OR 0.44, 95% CI 0.25-0.76, p = 0.003) were significantly associated with NAION. At multivariate analysis, adjusted for age, gender, smoking habit, hypertension, dyslipidemia, diabetes, sleep apnea, and thrombophilic risk factors, the higher homocysteine and Lp(a) values (OR 5.74, 95% CI 2.41-13.67, p = 0.0001; OR 1.27, 95% CI 1.01-1.63, p = 0.04) and lower vitamin B6 values (OR 0.42, 95% CI 0.23-0.77, p = 0.005) maintained their significant relationship with NAION.

Conclusions: This study demonstrated that elevated plasma homocysteine and lipoprotein(a) levels, as well as low vitamin B6 levels, may increase the risk of developing NAION. A screening for these thrombophilic markers could be useful in subjects experiencing NAION.

Comment in

Similar articles

See all similar articles

Cited by 12 PubMed Central articles

See all "Cited by" articles

References

    1. Acta Ophthalmol Scand. 2004 Apr;82(2):140-3 - PubMed
    1. Curr Opin Ophthalmol. 1999 Dec;10(6):474-82 - PubMed
    1. Clin Chem Lab Med. 2001 Aug;39(8):725-33 - PubMed
    1. Arch Ophthalmol. 1985 Aug;103(8):1143-4 - PubMed
    1. Am J Ophthalmol. 2001 May;131(5):671-3 - PubMed

MeSH terms

LinkOut - more resources

Feedback